HYBRID EVENT: You can participate in PERSON or VIRTUAL from your Home/Work.

3ʳᵈ International conference on

Oncology and Cancer Research

March 18-19, 2026 | DUBAI, UAE

Abstract Submission

Abstract Submission

Submission Guidelines

  • Abstracts should be in A4 size portrait layout.
  • The Title of the Abstract should be as concise as possible and should appear in bold, lower case and centred.
  • Co-authors and affiliations below the title in italics (the Presenting author’s name should be Bold with an asterisk (*).
  • Abstract must be written in English and content should have a maximum of 200-300 words.
  • Main body of text to be left aligned & Single spacing throughout the content.
  • Abstracts should be uploaded or sent in MS Word or PDF attachment through conference mail id or you can submit it here.
  • Please include your full address and contact details of the main author in the email and indicate whether you are submitting an Oral or Poster Presentation.
  • Our Conference Co-ordinator will get in touch with you after receiving your abstract.
  • All Submitted Abstracts will go through a peer review process carried out by a peer review committee. After successful review of your abstract, we will guide you for further steps towards your presence at our event.

Topics

Track 1: Cancer
Track 2: Oncology
Track 3: Chemotherapy
Track 4: AI in Cancer
Track 5: Breast Cancer
Track 6: Clinical Oncology
Track 7: Blood Cancer
Track 8: Cancer Epidemiology
Track 9: Cancer Biology
Track 10: Cancer Nanotechnology
Track 11: Pediatric Oncology
Track 12: Cancer Biomarkers
Track 13: Precision Oncology
Track 14: Cancer Detection
Track 15: Cancer Screening
Track 16: Cancer Diagnosis
Track 17: Cancer Pharmacology
Track 18: Drug Development
Track 19: Cancer Stem Cell Therapy
Track 20: Adolescent Oncology
Track 21: Surgical Oncology
Track 22: Cancer Research
Track 23: Cancer Treatment
Track 24: Head and Neck Cancer
Track 25: Skin Cancer
Track 26: Medical Oncology
Track 27: Covid and Its Impact on Cancer
Track 28: Radiation Oncology
Track 29: Gynecologic Cancer
Track 30: Cancer Metastasis